Takahiro Osuga

Sapporo, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications

Hepatocellular Carcinoma Presenting with Pseudoprogression in a Patient Receiving Atezolizumab Plus Bevacizumab Combination Therapy.

Hepatocellular Carcinoma Presenting with Pseudoprogression in a Patient Receiving Atezolizumab Plus Bevacizumab Combination Therapy.

Journal: Internal medicine (Tokyo, Japan)
Published: January 05, 2025

Pulmonary Metastasectomy after Radiofrequency Ablation of Hepatocellular Carcinoma.

Pulmonary Metastasectomy after Radiofrequency Ablation of Hepatocellular Carcinoma.

Journal: Case reports in oncology
Published: December 11, 2023

Synergistic antitumor effect of histone deacetylase class IIa inhibitor with lenvatinib in hepatocellular carcinoma.

Synergistic antitumor effect of histone deacetylase class IIa inhibitor with lenvatinib in hepatocellular carcinoma.

Journal: Hepatology international
Published: November 08, 2022

Association between Hepatic Oxidative Stress Related Factors and Activation of Wnt/β-Catenin Signaling in NAFLD-Induced Hepatocellular Carcinoma.

Association between Hepatic Oxidative Stress Related Factors and Activation of Wnt/β-Catenin Signaling in NAFLD-Induced Hepatocellular Carcinoma.

Journal: Cancers
Published: March 30, 2022

A Case of Unresectable Combined Hepatocellular-Cholangiocarcinoma Successfully Treated with Lenvatinib.

A Case of Unresectable Combined Hepatocellular-Cholangiocarcinoma Successfully Treated with Lenvatinib.

Journal: Case reports in oncology
Published: January 26, 2022

A case of acute exacerbation of chronic hepatitis C during the course of adrenal Cushing's syndrome.

A case of acute exacerbation of chronic hepatitis C during the course of adrenal Cushing's syndrome.

Journal: Clinical case reports
Published: December 02, 2021

Programmed cell death ligand 1 expression in a case of poorly differentiated lymphocyte-rich hepatocellular carcinoma.

Programmed cell death ligand 1 expression in a case of poorly differentiated lymphocyte-rich hepatocellular carcinoma.

Journal: Clinical case reports
Published: May 24, 2021

Combination of psoas muscle mass index and neutrophil/lymphocyte ratio as a prognostic predictor for patients undergoing nonsurgical hepatocellular carcinoma therapy.

Combination of psoas muscle mass index and neutrophil/lymphocyte ratio as a prognostic predictor for patients undergoing nonsurgical hepatocellular carcinoma therapy.

Journal: JGH open : an open access journal of gastroenterology and hepatology
Published: February 23, 2021

MUTYH is associated with hepatocarcinogenesis in a non-alcoholic steatohepatitis mouse model.

MUTYH is associated with hepatocarcinogenesis in a non-alcoholic steatohepatitis mouse model.

Journal: Scientific reports
Published: October 25, 2020

A case of hypervascular tumors in the liver and pancreas: synchronous hepatocellular carcinoma and pancreatic metastasis from renal cell carcinoma 36 years after nephrectomy.

A case of hypervascular tumors in the liver and pancreas: synchronous hepatocellular carcinoma and pancreatic metastasis from renal cell carcinoma 36 years after nephrectomy.

Journal: Clinical case reports
Published: September 16, 2020

Combination of eribulin plus AKT inhibitor evokes synergistic cytotoxicity in soft tissue sarcoma cells.

Combination of eribulin plus AKT inhibitor evokes synergistic cytotoxicity in soft tissue sarcoma cells.

Journal: Scientific reports
Published: November 16, 2018

Neoadjuvant chemotherapy with docetaxel, nedaplatin, and fluorouracil for resectable esophageal cancer: A phase II study.

Neoadjuvant chemotherapy with docetaxel, nedaplatin, and fluorouracil for resectable esophageal cancer: A phase II study.

Journal: Cancer science
Published: June 22, 2018
Showing 1-12 of 25

Last Updated: 09/26/2026